Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema

NCT05217680 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

510

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

BIOLOGICAL: Bevacizumab
BIOLOGICAL: Lucentis®

Sponsor

Laboratorios Sophia S.A de C.V.